Latest Insider Transactions at Moelis & CO (MC)
This section provides a real-time view of insider transactions for Moelis & CO (MC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moelis & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moelis & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 09
2020
|
Joseph Simon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,984
-100.0%
|
$265,392
$38.1 P/Share
|
|
Nov 05
2020
|
Joseph Simon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,934
-44.73%
|
$605,492
$38.16 P/Share
|
|
Nov 04
2020
|
Joseph Simon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
18,367
-25.22%
|
$697,946
$38.68 P/Share
|
|
Oct 30
2020
|
Navid Mahmoodzadegan Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Indirect |
10
+100.0%
|
-
|
|
Oct 30
2020
|
Jeffrey Raich Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
10
+100.0%
|
-
|
|
Oct 28
2020
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
2,097
-2.45%
|
$81,783
$39.28 P/Share
|
|
Oct 28
2020
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
4,620
+5.13%
|
-
|
|
Oct 27
2020
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Indirect |
1,195,848
-100.0%
|
$45,442,224
$38.55 P/Share
|
|
Oct 27
2020
|
Navid Mahmoodzadegan Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,195,838
+50.0%
|
-
|
|
Oct 27
2020
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,406
+0.84%
|
-
|
|
Oct 27
2020
|
Jeffrey Raich Co-President, MD |
SELL
Open market or private sale
|
Indirect |
633,100
-100.0%
|
$24,057,800
$38.55 P/Share
|
|
Oct 27
2020
|
Jeffrey Raich Co-President, MD |
SELL
Open market or private sale
|
Direct |
364
-100.0%
|
$13,832
$38.55 P/Share
|
|
Oct 27
2020
|
Jeffrey Raich Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Indirect |
633,100
+50.0%
|
-
|
|
Oct 27
2020
|
Jeffrey Raich Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
354
+50.0%
|
-
|
|
Oct 08
2020
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
20,000
-75.31%
|
$760,000
$38.0 P/Share
|
|
Oct 02
2020
|
Elizabeth Crain |
SELL
Open market or private sale
|
Indirect |
12,455
-100.0%
|
$448,380
$36.0 P/Share
|
|
Oct 02
2020
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
7,545
-22.12%
|
$271,620
$36.0 P/Share
|
|
Sep 30
2020
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.65%
|
-
|
|
Sep 30
2020
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.69%
|
-
|
|
Sep 30
2020
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.7%
|
-
|
|
Sep 30
2020
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
15,000
-30.55%
|
$525,000
$35.0 P/Share
|
|
Sep 30
2020
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.69%
|
-
|
|
Sep 30
2020
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.7%
|
-
|
|
Sep 30
2020
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.62%
|
-
|
|
Sep 30
2020
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.69%
|
-
|
|
Sep 30
2020
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.7%
|
-
|